Bernard Wealth Management Corp.
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 2056313
ROYAL OAK, MI
Position in ARWR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,837
-$461 QoQ
Shares Held
125
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bernard Wealth Management Corp. holds $35,144 across 9 Biotechnology names. ARWR ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,520 | $20,235 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
125 | $7,837 | |
| 3 | MRNA |
Moderna, Inc.
|
50 | $2,540 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5 | $2,232 | |
| 5 | CGEN |
Compugen Ltd
|
400 | $852 | |
| 6 | TLSA |
Tiziana Life Sciences Ltd
|
500 | $585 | |
| 7 | NNVC |
Nanoviricides, Inc.
|
500 | $455 | |
| 8 | GNPX |
Genprex, Inc.
|
200 | $362 |
All Filings in ARWR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,837 | 125 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,298 | 125 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $4,311 | 125 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,975 | 125 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,592 | 125 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,350 | 125 | Shares | Sole | 2025-02-27 | |
| No filing history on record for this holder in this stock. | ||||||